Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-012678
Filing Date
2025-05-12
Accepted
2025-05-12 17:00:16
Documents
1
Period of Report
2025-05-08

Document Format Files

Seq Description Document Type Size
1 form4-05122025_050503.html 4  
1 form4-05122025_050503.xml 4 4317
  Complete submission text file 0001415889-25-012678.txt   5924
Mailing Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103 239-302-1707
Enveric Biosciences, Inc. (Issuer) CIK: 0000890821 (see all company filings)

EIN.: 954484725 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 155 RANCHRIDGE DRIVE NW CALGARY, ALBERTA Z4 T3G 1W1
Business Address
Facchini Peter J. (Reporting) CIK: 0001883966 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38286 | Film No.: 25935820